Evaluation of effects of Covexir(R) on the immune system in healthy volunteers
Phase 1
- Conditions
- Healthy volunteers.
- Registration Number
- IRCT20180103038199N13
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 32
Inclusion Criteria
Age more than 18 years old
Healthy volunteers (Confirmed by history, physical examination and routine blood tests)
Consent to admission to the study
Three injections of the inactivated Covid-19 vaccines and at least two months have passed since the last injection.
Not being infected with Covid-19 by using a rapid corona test and evaluating clinical symptoms.
Exclusion Criteria
Having any diseases
Taking other medications
Taking any herbal products and supplements
Taking Covexir (R) within the previous 6 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of parameters related to the immune system (including hs-CRP level). Timepoint: At the beginning of the study, after 2 weeks of treatment, and after 4 weeks of treatment. Method of measurement: Laboratory kit.
- Secondary Outcome Measures
Name Time Method